Medical Laboratory · H

ASCP BOC Scientist in Hematology (H) Examination Practice Test

Hematology examines blood cells, bone marrow production, hemoglobin, and hemostasis. Practice questions sample recognition of leukocyte morphology, blood collection and anticoagulants, anemia-related findings, coagulation patterns, and disorders such as leukemia and disseminated intravascular coagulation. These concepts support interpretation of complete blood counts, peripheral blood smears, and coagulation results in the clinical laboratory.

Exam overview

Exam providerASCP Board of Certification
Exam codeH
CategoryMedical Laboratory

About the ASCP BOC Scientist in Hematology (H) Examination Exam

Hematology work requires connecting cell appearance and counts with blood-cell development and disease processes. Practice scenarios may ask you to distinguish a reactive leukocyte pattern from a clonal myeloid disorder, relate abnormal blood-cell findings to hematopoiesis, or identify hemoglobin patterns. Coagulation questions call for interpreting prothrombin time and activated partial thromboplastin time, recognizing factor-related patterns, and understanding how thrombin converts fibrinogen to fibrin. They may also address selecting the appropriate test for monitoring anticoagulant therapy and identifying combined abnormalities associated with consumptive coagulopathy. Accurate decisions depend on knowing specimen requirements, including the role of EDTA in CBC collection, and integrating results rather than interpreting one laboratory value in isolation.

Sample Practice Questions

Review a selection from this exam's published US Practice Tests practice bank.

Question 1

Which mature circulating leukocyte normally has a bilobed nucleus and prominent orange-red cytoplasmic granules?

  1. AEosinophil
  2. BMonocyte
  3. CSmall lymphocyte
  4. DBasophil
Show answerCorrect answer: A

Eosinophils typically have a bilobed nucleus and conspicuous orange-red granules. They participate in responses to parasites and in allergic and inflammatory conditions.

Question 2

Which anticoagulant is commonly used in a lavender-top tube for a complete blood count?

  1. AEDTA
  2. BSodium citrate
  3. CLithium heparin
  4. DSodium fluoride
Show answerCorrect answer: A

EDTA chelates calcium and is the standard anticoagulant for routine CBC testing because it preserves cellular morphology reasonably well when the specimen is mixed and processed appropriately.

Question 3

A patient has a markedly prolonged prothrombin time and a normal activated partial thromboplastin time. Which factor deficiency is most directly suggested by this pattern?

  1. AFactor VII
  2. BFactor VIII
  3. CFactor IX
  4. DFactor XII
Show answerCorrect answer: A

Factor VII is part of the extrinsic pathway assessed by the prothrombin time. An isolated factor VII deficiency can prolong PT while leaving aPTT within the reference interval.

Question 4

Which finding is most characteristic of chronic myeloid leukemia in chronic phase?

  1. AMarked leukocytosis with a spectrum of granulocytic maturation
  2. BIsolated severe thrombocytopenia with normal leukocyte count
  3. CPredominance of mature lymphocytes with smudge cells
  4. DAuer rods in most circulating leukocytes
Show answerCorrect answer: A

Chronic myeloid leukemia typically presents with leukocytosis and granulocytes at multiple stages of maturation, often with basophilia. Auer rods are associated with myeloid blasts rather than being a defining feature of chronic-phase CML.

Question 5

Which coagulation test is most directly used to monitor unfractionated heparin therapy?

  1. AProthrombin time
  2. BActivated partial thromboplastin time
  3. CThrombin time only
  4. DBleeding time
Show answerCorrect answer: B

Unfractionated heparin is commonly monitored using the activated partial thromboplastin time (aPTT), or an anti-factor Xa assay depending on the laboratory protocol. PT is generally used to monitor warfarin.

Question 6

In adults, where does most hematopoiesis normally occur?

  1. ARed marrow of the axial skeleton
  2. BThymic cortex
  3. CSpleen red pulp exclusively
  4. DYellow marrow of long-bone shafts
Show answerCorrect answer: A

In healthy adults, active hematopoiesis is concentrated in red marrow, especially in the axial skeleton and selected proximal portions of long bones. The thymus is primarily a site of T-cell maturation, while yellow marrow is predominantly adipose tissue.

Question 7

Which laboratory pattern is most consistent with disseminated intravascular coagulation?

  1. ALow platelet count, prolonged PT and aPTT, and increased D-dimer
  2. BHigh platelet count, shortened PT, and decreased D-dimer
  3. CNormal platelet count, isolated prolonged PT, and normal fibrinogen
  4. DLow platelet count, normal PT and aPTT, and decreased D-dimer
Show answerCorrect answer: A

DIC involves systemic coagulation activation and consumption of platelets and clotting factors. Typical findings include thrombocytopenia, prolonged PT and aPTT, increased fibrin degradation products such as D-dimer, and often reduced fibrinogen.

How to use this practice test

The free practice set draws up to 20 random questions from the available 50-question bank. Use each session to check recognition of hematology terminology and application of cell morphology, CBC, and coagulation concepts. Results appear after the session, helping you identify which question areas to revisit.

Preparation tips

  • Compare eosinophil, neutrophil, lymphocyte, monocyte, and basophil morphology, including nuclear shape and cytoplasmic granules.
  • Review hematopoiesis by cell lineage and site, then connect abnormal counts or smear findings with possible reactive and neoplastic patterns.
  • Practice interpreting PT and aPTT together; distinguish isolated test prolongation from patterns involving multiple coagulation pathways.
  • Study the roles of EDTA, citrate, and heparin in laboratory specimens, and match each anticoagulant to appropriate testing.
  • Trace fibrin formation from thrombin-mediated fibrinogen conversion, and review how anticoagulant monitoring differs from diagnosing a coagulation disorder.
Official sourceOfficial exam page ↗Official exam guide ↗